Skip to main content
Have a personal or library account? Click to login
Tumor size and effectiveness of electrochemotherapy Cover

Tumor size and effectiveness of electrochemotherapy

Radiology and Oncology
Volume 47 (2013): Issue 1 (March 2013)
By: ,  ,  ,  ,  ,   and    
Open Access
|Feb 2013
References

References

  1. 1. Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M, et al. Electrochemotherapy - An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study.2006;3-13.
    Open DOISearch in Google Scholar
  2. 2. Sersa G, Miklavcic D, Cemazar M, Rudolf Z, Pucihar G, Snoj M. Electrochemotherapy in treatment of tumours.2008;232-240.
    Open DOISearch in Google Scholar
  3. 3. Snoj M, Rudolf Z, Cemazar M, Jancar B, Sersa G. Successful sphincter-saving treatment of anorectal malignant melanoma with electrochemotherapy, local excision and adjuvant brachytherapy.2005;345-348.
    Open DOISearch in Google Scholar
  4. 4. Snoj M, Cemazar M, Srnovrsnik T, Paulin-Kosir SM, Sersa G. Limb sparing treatment of bleeding melanoma recurrence by electrochemotherapy.2009;398-402.
    Open DOISearch in Google Scholar
  5. 5. Colombo GL, Di Matteo S, Mir LM. Cost-effectiveness analysis of electrochemotherapy with the CliniporatorTM vs other methods for the control and treatment of cutaneous and subcutaneous tumors.2008;541-548.
    Open DOISearch in Google Scholar
  6. 6. Moller MG, Salwa S, Soden DM, O’Sullivan GC. Electrochemotherapy as an adjunct or alternative to other treatments for unresectable or in-transit melanoma.2009;1611-1630.
    Open DOISearch in Google Scholar
  7. 7. Testori A, Faries MB, Thompson JF, Pennacchioli E, Deroose JP, van Geel AN, et al. Local and intralesional therapy of in-transit melanoma metastases.2011;391-396.
    Open DOISearch in Google Scholar
  8. 8. Mir LM, Gehl J, Sersa G, Collins CG, Garbay JR, Billard V, et al. Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or noninvasive electrodes.2006;14-25.
    Open DOISearch in Google Scholar
  9. 9. Campana LG, Mocellin S, Basso M, Puccetti O, De Salvo GL, Chiarion-Sileni V, et al. Bleomycin-based electrochemotherapy: clinical outcome from a single institution’s experience with 52 patients.2009;191-199.
    Open DOISearch in Google Scholar
  10. 10. Curatolo P, Quaglino P, Marenco F, Mancini M, Nardo T, Mortera C, et al. Electrochemotherapy in the treatment of Kaposi sarcoma cutaneous lesions: a two-center prospective phase II trial.2012;192-198.
    Open DOISearch in Google Scholar
  11. 11. Quaglino P, Mortera C, Osella-Abate S, Barberis M, Illengo M, Rissone M, et al. Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases.2008;2215-2222.
    Open DOISearch in Google Scholar
  12. 12. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.2009;b2700.
    Open DOISearch in Google Scholar
  13. 13. Wieseler B, McGauran N. Reporting a systematic review.2010;1240-1246.
    Open DOISearch in Google Scholar
  14. 14. Higgins JPT, Green S.. UK: Wiley-Blackwell; 2008.
    Open DOISearch in Google Scholar
  15. 15. World Health Organization.. Switzerland: World Health Organization; 1979.
    Search in Google Scholar
  16. 16. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors.2000;205-216.
    Open DOISearch in Google Scholar
  17. 17. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR.. UK: Wiley; 2009.
    Open DOISearch in Google Scholar
  18. 18. Byrne CM, Thompson JF, Johnston H, Hersey P, Quinn MJ, Hughes TM, et al. Treatment of metastatic melanoma using electroporation therapy with bleomycin (electrochemotherapy).2005;45-51.
    Open DOISearch in Google Scholar
  19. 19. Landstrom FJ, Nilsson COS, Crafoord S, Reizenstein JA, Adamsson GBM, Lofgren LA. Electroporation therapy of skin cancer in the head and neck area.2010;1245-1250.
    Open DOISearch in Google Scholar
  20. 20. Larkin JO, Collins CG, Aarons S, Tangney M, Whelan M, O’Reily S, et al. Electrochemotherapy - Aspects of preclinical development and early clinical experience.2007;469-479.
    Open DOISearch in Google Scholar
  21. 21. Matthiessen LW, Chalmers RL, Sainsbury DCG, Veeramani S, Kessell G, Humphreys AC, et al. Management of cutaneous metastases using electrochemotherapy.2011;621-629.
    Open DOISearch in Google Scholar
  22. 22. Rols MP, Bachaud JM, Giraud P, Chevreau C, Roche H, Teissie J. Electrochemotherapy of cutaneous metastases in malignant melanoma.2000;468-474.
    Open DOISearch in Google Scholar
  23. 23. Domenge C, Orlowski S, Luboinski B, DeBaere T, Schwaab G, Belehradek J, et al. Antitumor electrochemotherapy - New advances in the clinical protocol.1996;956-963.
    Open DOISearch in Google Scholar
  24. 24. Miklavcic D, Beravs K, Semrov D, Cemazar M, Demsar F, Sersa G. The importance of electric field distribution for effective in vivo electroporation of tissues.1998;2152-2158.
    Open DOISearch in Google Scholar
  25. 25. Miklavcic D, Corovic S, Pucihar G, Pavselj N. Importance of tumour coverage by sufficiently high local electric field for effective electrochemotherapy.2006;45-51.
    Open DOISearch in Google Scholar
  26. 26. Miklavcic D, Towhidi L. Numerical study of the electroporation pulse shape effect on molecular uptake of biological cells.2010;34-41.
    Open DOISearch in Google Scholar
  27. 27. Cemazar M, Milacic R, Miklavcic D, Dolzan V, Sersa G. Intratumoral cisplatin administration in electrochemotherapy: antitumor effectiveness, sequence dependence and platinum content.1998;525-530.
    Open DOISearch in Google Scholar
  28. 28. Front D, Israel O, Iosilevsky G, Even-Sapir E, Ben-Haim S, Frenkel A, et al. Administered dose and tumor dose of bleomycin labeled with cobalt-57 in mice and men.1990;1784-1790.
    Search in Google Scholar
  29. 29. Mir LM, Tounekti O, Orlowski S. Bleomycin: Revival of an old drug.1996;745-748.
    Open DOISearch in Google Scholar
  30. 30. Hall SW, Strong JE, Broughton A, Frazier ML, Benjamin RS. Bleomycin clinical pharmacology by radioimmunoassay.1982;22-25.
    Open DOISearch in Google Scholar
  31. 31. Alberts DS, Chen HS, Liu R, Himmelstein KJ, Mayersohn M, Perrier D, et al. Bleomycin pharmacokinetics in man. I. Intravenous administration.1978;177-181.
    Search in Google Scholar
  32. 32. Sersa G, Jarm T, Kotnik T, Coer A, Podkrajsek M, Sentjurc M, et al. Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma.2008;388-398.
    Open DOISearch in Google Scholar
  33. 33. Sersa G, Krzic M, Sentjurc M, Ivanusa T, Beravs K, Kotnik V, et al. Reduced blood flow and oxygenation in SA-1 tumours after electrochemotherapy with cisplatin.2002;1047-1054.
    Open DOISearch in Google Scholar
  34. 34. Sersa G, Cemazar M, Miklavcic D. Tumor blood flow modifying effects of electrochemotherapy: a potential vascular targeted mechanism.2003;43-48.
    Search in Google Scholar
  35. 35. Jarm T, Cemazar M, Miklavcic D, Sersa G. Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases.2010;729-746.
    Open DOISearch in Google Scholar
  36. 36. Miklavcic D, Snoj M, Zupanic A, Kos B, Cemazar M, Kropivnik M, et al. Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy.2010;10
    Open DOISearch in Google Scholar
  37. 37. Edhemovic I, Gadzijev EM, Brecelj E, MIklavcic M, Kos B, Zupanic A, et al. Electrochemotherapy: a new technological approach in treatment of metastases in the liver.2011;475-485.
    Open DOISearch in Google Scholar
  38. 38. Pavliha D, Kos B, Zupanic A, Marcan M, Sersa G, Miklavcic D. Patient-specific treatment planning of electrochemotherapy: Procedure design and possible pitfalls.2012;265-273.
    Open DOISearch in Google Scholar
  39. 39. Adeyanju OO, Al-Angari HM, Sahakian AV. The optimization of needle electrode number and placement for irreversible electroporation of hepatocellular carcinoma.2012;126-135.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/raon-2013-0002 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 32 - 41
Published on: Feb 1, 2013
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
electrochemotherapy,
cutaneous tumors,
effectiveness,
tumor size,
meta-analysis
Related subjects:
Medicine,
Clinical medicine,
Radiology

© 2013 Barbara Mali, Damijan Miklavcic, Luca G. Campana, Maja Cemazar, Gregor Sersa, Marko Snoj, Tomaz Jarm, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 47 (2013): Issue 1 (March 2013)
Previous article
Next article